KR102631008B1 - Cosmetic composition and method for producing the same - Google Patents
Cosmetic composition and method for producing the same Download PDFInfo
- Publication number
- KR102631008B1 KR102631008B1 KR1020230192378A KR20230192378A KR102631008B1 KR 102631008 B1 KR102631008 B1 KR 102631008B1 KR 1020230192378 A KR1020230192378 A KR 1020230192378A KR 20230192378 A KR20230192378 A KR 20230192378A KR 102631008 B1 KR102631008 B1 KR 102631008B1
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- skin
- paragraph
- extract
- acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 239000002537 cosmetic Substances 0.000 title claims abstract description 50
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- 239000000284 extract Substances 0.000 claims description 32
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 claims description 22
- 239000006210 lotion Substances 0.000 claims description 22
- 239000004615 ingredient Substances 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 19
- -1 cleansing Substances 0.000 claims description 17
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 16
- 229960002350 guaiazulen Drugs 0.000 claims description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 230000003020 moisturizing effect Effects 0.000 claims description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- 239000010495 camellia oil Substances 0.000 claims description 8
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 8
- 239000011666 cyanocobalamin Substances 0.000 claims description 8
- 229960002104 cyanocobalamin Drugs 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 244000170916 Paeonia officinalis Species 0.000 claims description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- 229960001631 carbomer Drugs 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 3
- 239000004386 Erythritol Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 229940069521 aloe extract Drugs 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 239000003708 ampul Substances 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 229940059958 centella asiatica extract Drugs 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 229940113120 dipropylene glycol Drugs 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 229940101267 panthenol Drugs 0.000 claims description 3
- 235000020957 pantothenol Nutrition 0.000 claims description 3
- 239000011619 pantothenol Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 235000013772 propylene glycol Nutrition 0.000 claims description 3
- 239000002453 shampoo Substances 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 229960002920 sorbitol Drugs 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 229960000281 trometamol Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 244000183278 Nephelium litchi Species 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 2
- 229960002900 methylcellulose Drugs 0.000 claims description 2
- 229940070721 polyacrylate Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 208000003251 Pruritus Diseases 0.000 abstract description 6
- 230000036560 skin regeneration Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000007803 itching Effects 0.000 abstract description 5
- 230000000887 hydrating effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 58
- 238000000034 method Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000011148 porous material Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 230000037394 skin elasticity Effects 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000042664 Matricaria chamomilla Species 0.000 description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005722 itchiness Effects 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- MYUIQELNVKTIDO-UHFFFAOYSA-N [Na].O=S(=O)=O Chemical compound [Na].O=S(=O)=O MYUIQELNVKTIDO-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- ZWXYEWJNBYQXLK-UHFFFAOYSA-N azanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O ZWXYEWJNBYQXLK-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 210000000437 stratum spinosum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 화장료 조성물에 관한 것으로, 보다 상세하게는, 피부의 재생과 진정, 수분 공급과 가려움증 완화 효능이 우수하고, 혈액 순환을 도와 피부의 생기와 탄력을 부여할 수 있도록 하는, 화장료 조성물 및 이의 제조방법에 관한 것이다. The present invention relates to a cosmetic composition, and more specifically, to a cosmetic composition and the same that are excellent in skin regeneration and soothing, hydrating and itching alleviating effects, and help blood circulation to give vitality and elasticity to the skin. It is about manufacturing method.
Description
본 발명은 화장료 조성물에 관한 것으로, 보다 상세하게는, 피부의 재생과 진정, 수분 공급과 가려움증 완화 효능이 우수하고, 혈액 순환을 도와 피부의 생기와 탄력을 부여할 수 있도록 하는, 화장료 조성물 및 이의 제조방법에 관한 것이다. The present invention relates to a cosmetic composition, and more specifically, to a cosmetic composition and the same that are excellent in skin regeneration and soothing, hydrating and itching alleviating effects, and help blood circulation to give vitality and elasticity to the skin. It is about manufacturing method.
인체 피부의 주요 기능은 자외선 차단, 미생물, 화학 물질 등의 외부 오염물질의 차단과 체내 온도 조절이다. 피부는 표면으로부터 차례로 표피, 진피, 피하 지방층으로 구성되고, 그 밖에 모공 및 땀샘으로 구성되어 있다.The main functions of human skin are to block ultraviolet rays, block external pollutants such as microorganisms and chemicals, and regulate body temperature. Starting from the surface, the skin is composed of the epidermis, dermis, and subcutaneous fat layer, and is also composed of pores and sweat glands.
표피층은 각질층, 과립층, 유극층 및 기저층으로 구성되어 있고, 이 중 각질층은 피부장벽을 구성하여 외부물질로부터 차단 및 진피층의 수분유지기능을 담당하고 있다. 표피층은 약 10 내지 20㎛의 두께이며, 단백질로 꽉 찬 세포들이 세포사이의 비극성 층판 지질에 파묻혀있는 형상이다. 피부장벽의 핵심이 되는 지질층의 주성분은 콜레스테롤(30%), 자유지방산(15%), 세라마이드(50%)이다. 지질층의 주성분들은 과립층의 층판소체로부터 유래된다.The epidermal layer is composed of the stratum corneum, granular layer, stratum spinosum, and basal layer. Among these, the stratum corneum constitutes the skin barrier and is responsible for blocking external substances and maintaining moisture in the dermal layer. The epidermal layer is about 10 to 20㎛ thick and has protein-filled cells buried in non-polar lamellar lipids between cells. The main components of the lipid layer, which is the core of the skin barrier, are cholesterol (30%), free fatty acids (15%), and ceramide (50%). The main components of the lipid layer are derived from lamellar bodies of the granular layer.
모공에는 피지선이라 하여 피지를 분비하는 기관이 있다. 여기서 모낭으로 분비되고, 땀을 통해 피지가 몸 밖으로 배출 될 때 장애가 생기면 모공이 커지게 된다. 모공이 넓어지면 피부가 건조해지고 탄력이 없어진다. Pores contain organs called sebaceous glands that secrete sebum. From here, it is secreted into the hair follicles, and if there is a problem when sebum is discharged out of the body through sweat, the pores become enlarged. When pores become enlarged, the skin becomes dry and loses elasticity.
피부온도와 피지 및 모공과의 상관관계는 여러 논문을 통해 밝혀진 바가 있으며, 일반적으로 피부온도가 높아질 경우 더욱 건조해지고 모공이 넓어진다는 보고가 있다. 뿐만 아니라 블랙헤드, 여드름도 피부온도와 상관관계가 있다는 사실이 알려졌다. The correlation between skin temperature and sebum and pores has been revealed in several papers, and there are reports that generally, when skin temperature rises, it becomes drier and pores become larger. In addition, it is known that blackheads and acne are correlated with skin temperature.
따라서, 피부온도를 낮춰주는 쿨링효과 및 진정효과가 있는 화장품을 사용하면 피부보습, 모공수축, 블랙헤드, 여드름에 도움이 되어 트러블이 적은 건강한 피부로 가꿀 수 있다.Therefore, using cosmetics with cooling and soothing effects that lower skin temperature can help moisturize the skin, shrink pores, blackheads, and acne, creating healthy skin with fewer problems.
한편, 각질세포는 표피 최하층에서 지속적으로 증식(proliferation)하는 기저세포(basal cell)가 단계적으로 형태 및 기능상의 변화를 거치며, 피부 표면까지 상승한 특징적인 세포이며, 일정 기간이 경과하면 오래된 각질세포는 피부에서 탈락되고 새로운 각질세포가 그 기능을 대신하게 되는데, 이러한 반복적인 일련의 변화 과정을 "표피 세포의 분화" 또는 "각화(keratinization)"라고 부른다. Meanwhile, keratinocytes are characteristic cells in which basal cells that continuously proliferate in the lowest layer of the epidermis gradually undergo changes in form and function and rise to the skin surface. After a certain period of time, old keratinocytes disappear. They are shed from the skin and new keratinocytes take over their function. This repetitive series of changes is called “epidermal cell differentiation” or “keratinization.”
또한, 각화 과정 중에 각질 형성세포는 천연보습인자(Natural moisturizing factor; NMF)와 세포간 지방질(세라마이드, 콜레스테롤, 지방산)을 생성하면서 각질층을 형성하여 각질층이 견고함과 유연성을 가지게 하여 피부 장벽(skin barrier)으로서의 기능을 보유하게 한다. In addition, during the keratinization process, keratinocytes produce natural moisturizing factor (NMF) and intercellular lipids (ceramide, cholesterol, fatty acids) to form the stratum corneum, making the stratum corneum firm and flexible, thereby strengthening the skin barrier. It functions as a barrier.
이러한 각질층은 과도한 세안이나, 목욕 등의 생활 습관적 요소나, 건조한 대기 오염 물질 등의 환경적인 요인, 및 아토피성 피부나 노인성 피부 같은 내인성 질환 등으로 인해 쉽게 그 기능이 손실될 수 있으며, 실제로 현대에 들어서 더욱 늘어난 다양한 요인들로 인해 최근에는 건조피부증상 및 이로 인한 제반 장해를 호소하는 부분들이 점점 증가하고 있는 추세이다. This stratum corneum can easily lose its function due to lifestyle factors such as excessive washing or bathing, environmental factors such as dry air pollutants, and endogenous diseases such as atopic skin or senile skin. In fact, in modern times, Recently, due to various factors that have increased, the number of people complaining of dry skin symptoms and various disorders resulting from it has been increasing.
이 밖에도, 건강한 피부라 할지라도 혹독한 외부환경, 즉, 바람, 추운 날씨, 햇빛, 세안, 면도 등에 의해 수분 부족현상이 일어나 피부상태가 나빠지기도 한다. 따라서 피부의 각질 세포층의 수분함량을 적절히 유지하는 것은 매우 중요하다. In addition, even if the skin is healthy, the skin condition may worsen due to lack of moisture due to harsh external environments, such as wind, cold weather, sunlight, washing the face, and shaving. Therefore, it is very important to maintain the appropriate moisture content of the skin's keratin cell layer.
이에, 본 발명자들은 피부 자극과 손상 등의 부작용이 적으면서, 피부 트러블 및 피부 손상에 대한 재생 효과를 가지고, 피부 열감에 대한 쿨링 및 진정 효과를 나타내며, 나아가, 피부 보습, 탄력, 미백 등에도 도움이 될 수 있도록 하는 최적 조성과 배합비를 갖는 화장료 조성물을 개발하기에 이르렀다. Accordingly, the present inventors have reduced side effects such as skin irritation and damage, have a regenerative effect on skin troubles and skin damage, have a cooling and soothing effect on hot skin, and further help with skin moisturization, elasticity, and whitening. We have developed a cosmetic composition with the optimal composition and mixing ratio that allows this.
본 발명은 상기와 같은 문제점을 해결하기 위한 것으로서, 피부의 재생과 진정, 수분 공급과 가려움증 완화 효능이 우수하고, 혈액 순환을 도와 피부의 생기와 탄력을 부여할 수 있도록 하는, 화장료 조성물 및 이의 제조방법을 제공하고자 한다. The present invention is intended to solve the above problems, and is a cosmetic composition that has excellent skin regeneration and soothing, moisturizing, and itching-relieving effects, and helps blood circulation to give vitality and elasticity to the skin, and its preparation. We would like to provide a method.
본 발명의 상기 및 다른 목적과 이점은 바람직한 실시예를 설명한 하기의 설명으로부터 분명해질 것이다.The above and other objects and advantages of the present invention will become apparent from the following description of preferred embodiments.
상기 목적은, 구아이아줄렌(Guaiazulene), 히알루론산(Hyaluronic acid), 시아노코발라민(Cyanocobalamin) 및 동백 오일(camellia oil)을 유효성분으로 포함하는 것을 특징으로 하는, 화장료 조성물에 의해 달성될 수 있다. The above objective can be achieved by a cosmetic composition, characterized in that it contains Guaiazulene, Hyaluronic acid, Cyanocobalamin and camellia oil as active ingredients. there is.
상기 유효 성분은, 상기 화장료 조성물 총 중량에 대하여, 0.1 내지 8 중량%로 포함되는 것을 특징으로 한다. The active ingredient is characterized in that it is contained in 0.1 to 8% by weight based on the total weight of the cosmetic composition.
상기 구아이아줄렌(Guaiazulene), 히알루론산(Hyaluronic acid), 시아노코발라민(Cyanocobalamin) 및 동백 오일(camellia oil)의 배합비는, 1 : 1~1.3 : 0.8~1 : 0.5~0.7의 중량비인 것을 특징으로 한다. The mixing ratio of Guaiazulene, Hyaluronic acid, Cyanocobalamin, and camellia oil is a weight ratio of 1: 1 to 1.3: 0.8 to 1: 0.5 to 0.7. It is characterized by
상기 화장료 조성물은 총 중량에 대하여, 천연 재료 추출물을 포함하는 제2 유효 성분을 0.01 내지 3.5 중량%로 더 포함하는 것을 특징으로 한다. The cosmetic composition is characterized in that it further contains 0.01 to 3.5% by weight of a second active ingredient containing extracts of natural ingredients, based on the total weight.
상기 제2 유효 성분은, 애기수영 추출물, 모란뿌리 추출물, 광나무 추출물, 나이아신 아마이드, 판토테닉 애씨드, 알란토인, 오렌지 추출물, 비오틴, 판테놀, 병풀 추출물, 알로에 추출물 및 이들의 조합 중에서 선택되는 어느 하나인 것을 특징으로 한다. The second active ingredient is any one selected from the group consisting of Achyranthes apiaceae extract, peony root extract, L. chinensis extract, niacinamide, pantothenic acid, allantoin, orange extract, biotin, panthenol, Centella asiatica extract, aloe extract, and combinations thereof. It is characterized by
상기 화장료 조성물은, 소듐하이알루로네이트, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 디프로필렌글리콜, 에리스리톨 및 소르비톨 중에서 선택되는 1종 이상의 보습제를 더 포함하는 것을 특징으로 한다. The cosmetic composition is characterized by further comprising at least one moisturizing agent selected from sodium hyaluronate, glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, erythritol, and sorbitol.
상기 화장료 조성물은, 폴리아크릴레이트, 잔탄검, 메틸셀룰로스, 하이드록시에틸셀룰로스, 카보머, 카라기난, 카르복시메틸셀룰로스 및 하이드록시메틸셀룰로스 중에서 선택되는 1종 이상의 점증제를 더 포함하는 것을 특징으로 한다. The cosmetic composition is characterized in that it further comprises one or more thickeners selected from polyacrylate, xanthan gum, methylcellulose, hydroxyethylcellulose, carbomer, carrageenan, carboxymethylcellulose and hydroxymethylcellulose.
상기 화장료 조성물은, 구연산, 수산화나트륨, 트리에탄올아민, 구연산나트륨, 인산, 인산나트륨, 젖산, 트로메타민 중에서 선택되는 1종 이상의 pH 조정제를 더 포함하는 것을 특징으로 한다. The cosmetic composition is characterized by further comprising at least one pH adjuster selected from citric acid, sodium hydroxide, triethanolamine, sodium citrate, phosphoric acid, sodium phosphate, lactic acid, and tromethamine.
상기 화장료 조성물은, 용액, 현탁액, 유탁액, 페이스트, 젤, 에센스, 크림, 로션, 앰플, 유연 화장수, 영양 화장수, 파우더, 비누, 클렌징, 오일, 파운데이션, 왁스, 팩, 파우더, 팩트, 립 글로즈, 립스틱, 섀도우, 샴푸, 린스 또는 스프레이 형태로 제조되는 것을 특징으로 한다. The cosmetic composition includes solution, suspension, emulsion, paste, gel, essence, cream, lotion, ampoule, softening lotion, nourishing lotion, powder, soap, cleansing, oil, foundation, wax, pack, powder, pact, lip gloss. , It is characterized in that it is manufactured in the form of lipstick, shadow, shampoo, rinse, or spray.
본 발명에 따르면, 피부의 재생과 진정, 수분 공급과 피부 각질 개선과 가려움증 완화 효능이 우수하고, 혈액 순환을 도와 피부의 생기와 미백을 부여하고 탄력성을 높일 수 있는 효능을 발휘할 수 있다. According to the present invention, it is excellent in regenerating and soothing the skin, supplying moisture, improving skin exfoliation, and alleviating itching, and can exert the effect of helping blood circulation, giving vitality and whitening to the skin, and increasing elasticity.
또한, 본 발명의 화장료 조성물은 피부 자극을 최소화하여 얼굴 피부 뿐만 아니라, 전신에도 사용가능하여 샤워 후 전신 마사지를 통해 피부의 건조함과 가려움증을 현저히 개선시킬 수 있다. In addition, the cosmetic composition of the present invention minimizes skin irritation and can be used not only on the facial skin but also on the entire body, so dryness and itchiness of the skin can be significantly improved through a full body massage after a shower.
상기 화장료 조성물은 예를 들어, 화장수, 에센스, 로션, 크림, 미스트 등의 다양한 제형과 제품 형태로 용이하게 제작될 수 있다. The cosmetic composition can be easily manufactured into various formulations and product forms, such as lotion, essence, lotion, cream, and mist.
다만, 본 발명의 효과들은 이상에서 언급한 효과로 제한되지 않으며, 언급되지 않은 또 다른 효과들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다. However, the effects of the present invention are not limited to the effects mentioned above, and other effects not mentioned will be clearly understood by those skilled in the art from the description below.
이하, 본 발명의 실시예와 도면을 참조하여 본 발명을 상세히 설명한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위해 예시적으로 제시한 것일 뿐, 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가지는 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in detail with reference to embodiments of the present invention and drawings. These examples are merely presented as examples to explain the present invention in more detail, and it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples. .
또한, 달리 정의하지 않는 한, 본 명세서에서 사용되는 모든 기술적 및 과학적 용어는 본 발명이 속하는 기술 분야의 숙련자에 의해 통상적으로 이해되는 바와 동일한 의미를 가지며, 상충되는 경우에는, 정의를 포함하는 본 명세서의 기재가 우선할 것이다.Additionally, unless otherwise defined, all technical and scientific terms used in this specification have the same meaning as commonly understood by a person skilled in the art to which the present invention pertains, and in case of conflict, this specification including definitions The description will take precedence.
도면에서 제안된 발명을 명확하게 설명하기 위해서 설명과 관계없는 부분은 생략하였으며, 명세서 전체를 통하여 유사한 부분에 대해서는 유사한 도면 부호를 붙였다. 그리고, 어떤 부분이 어떤 구성 요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다. 또한, 명세서에서 기술한 "부"란, 특정 기능을 수행하는 하나의 단위 또는 블록을 의미한다.In order to clearly explain the proposed invention in the drawings, parts unrelated to the description have been omitted, and similar reference numerals have been assigned to similar parts throughout the specification. And, when it is said that a part "includes" a certain component, this means that it does not exclude other components, but may further include other components, unless specifically stated to the contrary. Additionally, “unit” as used in the specification refers to a unit or block that performs a specific function.
각 단계들에 있어 식별부호(제1, 제2, 등)는 설명의 편의를 위하여 사용되는 것으로 식별부호는 각 단계들의 순서를 설명하는 것이 아니며, 각 단계들은 문맥상 명백하게 특정 순서를 기재하지 않는 이상 명기된 순서와 다르게 실시될 수 있다. 즉, 각 단계들은 명기된 순서와 동일하게 실시될 수도 있고 실질적으로 동시에 실시될 수도 있으며 반대의 순서대로 실시될 수도 있다.Identification codes (first, second, etc.) for each step are used for convenience of explanation. The identification codes do not describe the order of each step, and each step does not clearly state a specific order in context. It may be carried out differently from the order specified above. That is, each step may be performed in the same order as specified, may be performed substantially simultaneously, or may be performed in the opposite order.
본 발명에서 '추출물'이란, 당업계에 공지된 추출 및 분리하는 방법을 사용하여 천연 유래 성분 원료로부터 추출물을 분리 및 수득한 것을 의미하며, 본 발명에서 정의된 추출물은 적절한 용매를 이용하여 상기의 방법으로 준비된 성분 원료를 그대로 또는 분쇄하여 추출한 것일 수 있다. 이때 추출물을 수득하기 위해 사용할 수 있는 적절한 용매로는 당업계에서 허용되는 용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있다. 예를 들어, 정제수, 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올 (isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있으나, 이에 제한되지는 않는다. In the present invention, 'extract' means that an extract is separated and obtained from a natural ingredient raw material using extraction and separation methods known in the art, and the extract defined in the present invention is an extract as defined above using an appropriate solvent. The ingredient raw materials prepared by the method may be extracted as is or by pulverizing them. At this time, the appropriate solvent that can be used to obtain the extract may be any solvent acceptable in the art, and water or an organic solvent may be used. For example, alcohols with 1 to 4 carbon atoms, including purified water, methanol, ethanol, propanol, isopropanol, butanol, acetone, and ether. , various solvents such as benzene, chloroform, ethyl acetate, methylene chloride, hexane, and cyclohexane can be used individually or in combination. It is not limited.
추출 방법으로는 예를 들어, 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법, 적외선 추출법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. As an extraction method, for example, any one of the following methods can be selected and used: hot water extraction, cold needle extraction, reflux cooling extraction, solvent extraction, steam distillation, ultrasonic extraction, elution, compression, and infrared extraction.
또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 본 발명의 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다. In addition, the desired extract may be further subjected to a conventional fractionation process or may be purified using a conventional purification method. There is no limitation to the method for producing the extract of the present invention, and any known method can be used.
예를 들면, 본 발명의 조성물에 포함되는 추출물은 상기한 용매 추출법으로 추출된 1차 추출물을, 원심분리, 여과, 농축후 동결 건조하여 냉장실에 보관하면서 그대로 사용할 수도 있고, 상기 1차 추출물을 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. For example, the extract contained in the composition of the present invention may be used as is by centrifuging, filtering, concentrating, and then freeze-drying the primary extract extracted by the solvent extraction method described above and storing it in a refrigerator. The primary extract may be stored in a refrigerator under reduced pressure. It can be produced in powder form by additional processes such as distillation and freeze-drying or spray drying.
또한, 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography)등과 같은 다양한 크 로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다. In addition, the primary extract was further purified using various chromatographies such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography, etc. A fraction can also be obtained.
따라서, 본 발명에 있어서 “추출물”은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, in the present invention, “extract” is a concept that includes all extracts, fractions, and purifications obtained at each stage of extraction, fractionation, or purification, as well as their dilutions, concentrates, or dried products.
이하, 본원의 구현예 및 실시예를 상세히 설명한다. 그러나, 본원의 이러한 구현예 및 실시예와에 제한되지 않을 수 있다.Hereinafter, implementation examples and examples of the present application will be described in detail. However, the disclosure may not be limited to these embodiments and examples.
본원의 일 측면은, 구아이아줄렌(Guaiazulene), 히알루론산(Hyaluronic acid), 시아노코발라민(Cyanocobalamin) 및 동백 오일(camellia oil)을 유효성분으로 포함하는 것을 특징으로 하는, 화장료 조성물을 제공한다. One aspect of the present application provides a cosmetic composition comprising guaiazulene, hyaluronic acid, cyanocobalamin, and camellia oil as active ingredients. .
상기 구아이아줄렌(Guaiazulene)은, 캐머마일에서 얻은 순수 구아이아줄렌을 소르듐삼산화황으로 합성해서 만들어진 유기 화합물이다. 구아이아줄렌은 땅에서 나는 사과라는 뜻의 이름의 허브인 캐머마일의 오일에서 얻을 수 있는 성분이다. 캐머마일은 유럽, 북아프리카, 북아시아가 원산지이며, 달콤하고 상쾌한 사과향을 지녀 차로 즐기거나 목욕, 미용 등에 이용된다. The guaiazulene is an organic compound made by synthesizing pure guaiazulene obtained from chamomile with sodium sulfur trioxide. Guaiazulene is an ingredient obtained from the oil of chamomile, a herb whose name means apple that grows from the ground. Chamomile is native to Europe, North Africa, and North Asia. It has a sweet and refreshing apple scent and is enjoyed as a tea or used for bathing and beauty treatments.
상기 구아이아줄렌(Guaiazulene)은, 파란색을 나타내는 천연색소로 사용되고, 피부 진정, 피부 혈액 순환 및 회복, 피부 재생, 상처 치료용으로 사용되기에 적합하다. The guaiazulene is used as a natural pigment that exhibits blue color and is suitable for use in skin soothing, skin blood circulation and recovery, skin regeneration, and wound treatment.
상기 히알루론산(Hyaluronic acid)은, 건조한 피부에 수분을 제공하여 피부 보습력 증진, 주름 개선, 탄력 개선 등의 효능을 발휘한다. The hyaluronic acid provides moisture to dry skin and exerts effects such as improving skin moisturization, improving wrinkles, and improving elasticity.
상기 히알루론산은 상기 구아이아줄렌과 특정 중량비로 배합하여 함께 사용할 경우, 각 성분이 발휘하는 기능성에 대한 시너지가 극대화될 수 있다. When the hyaluronic acid is mixed with the guaiazulene at a specific weight ratio and used together, the synergy of the functionality of each ingredient can be maximized.
상기 시아노코발라민(Cyanocobalamin)은, 비타민 B12로, 분자 안에 코발트가 위치하며, 피부 컨디션을 조절하고, 피부 재생, 피부 톤 개선 효과가 우수하다. The cyanocobalamin (Cyanocobalamin) is vitamin B12, has cobalt located in the molecule, and has excellent effects in regulating skin condition, skin regeneration, and improving skin tone.
상기 동백 오일(camellia oil)은, 동백나무의 열매에서 추출되는 오일로, 우리나라와 중국, 일본 등 동아시아에서 주로 생산된다. 동백 오일에는 피부와 비슷한 성분인 올레인산이 함유되어 있어 피부에 친화적이며, 고보습, 영양 공급, 탄력 증진, 혈액 순환에 의한 피부 생기 부여 등의 효능을 발휘한다. The camellia oil is an oil extracted from the fruit of the camellia tree and is mainly produced in East Asia, such as Korea, China, and Japan. Camellia oil contains oleic acid, a component similar to skin, so it is friendly to the skin and has effects such as high moisturizing, supplying nutrients, improving elasticity, and revitalizing the skin through blood circulation.
상기 화장료 조성물 총 중량에 대하여, 상기 유효 성분은 0.01 내지 10 중량%, 구체적으로, 0.1 내지 8 중량%로 포함될 수 있다. Based on the total weight of the cosmetic composition, the active ingredient may be included in an amount of 0.01 to 10% by weight, specifically, 0.1 to 8% by weight.
상기 유효 성분을 전술된 함량 범위로 포함할 경우, 제형 안정성과 피부 쿨링, 진정 효과 및 피부 탄력 증진 효과에 대한 시너지가 가장 높게 나타날 수 있다. When the active ingredient is included in the above-described content range, the highest synergy in formulation stability, skin cooling, soothing effect, and skin elasticity enhancement effect can be achieved.
상기 구아이아줄렌(Guaiazulene), 히알루론산(Hyaluronic acid), 시아노코발라민(Cyanocobalamin) 및 동백 오일(camellia oil)의 배합비는, 1 : 1~1.3 : 0.8~1 : 0.5~0.7의 중량비, 일례로, 1 : 1.2 : 0.85 : 0.6의 중량비로 배합됨이 바람직하다. The mixing ratio of Guaiazulene, Hyaluronic acid, Cyanocobalamin and camellia oil is a weight ratio of 1: 1 to 1.3: 0.8 to 1: 0.5 to 0.7, an example. Therefore, it is preferable to mix at a weight ratio of 1:1.2:0.85:0.6.
상기 화장료 조성물은, 총 중량에 대하여, 천연 재료 추출물을 포함하는 제2 유효 성분을 0.01 내지 3.5 중량%로 더 포함할 수 있다. The cosmetic composition may further include 0.01 to 3.5% by weight of a second active ingredient containing extracts of natural ingredients, based on the total weight.
상기 제2 유효 성분은, 예를 들어, 애기수영 추출물, 모란뿌리 추출물, 광나무 추출물, 나이아신 아마이드, 판토테닉 애씨드, 알란토인, 오렌지 추출물, 비오틴, 판테놀, 병풀 추출물, 알로에 추출물 및 이들의 조합 중에서 선택되는 어느 하나일 수 있다. The second active ingredient is, for example, selected from the group consisting of Achyranthesia extract, peony root extract, Gwangju tree extract, niacinamide, pantothenic acid, allantoin, orange extract, biotin, panthenol, Centella asiatica extract, aloe extract, and combinations thereof. It could be any one.
일례로, 상기 제2 유효 성분은, 애기수영 추출물, 애기수영 추출물, 모란뿌리 추출물, 광나무 추출물, 나이아신 아마이드 및 판토테닉 애씨드의 혼합물일 수 있다. As an example, the second active ingredient may be a mixture of Agi swimming extract, Agi swimming extract, peony root extract, Chrysanthemum tree extract, niacinamide, and pantothenic acid.
전술된 성분들로 구성되는 상기 제2 유효 성분은, 앞서 전술된 유효 성분에 의해 피부 진정, 피부 쿨링감, 피부 재생, 보습력, 피부 탄력, 피부 생기 등의 기능성을 향상시키는 효과를 더욱 증대시킬 수 있으면서, 제2 유효 성분의 각 성분들이 갖는 효능을 화장료 조성물에 부가할 수 있다. The second active ingredient, which is composed of the above-mentioned ingredients, can further increase the effect of improving functionality such as skin soothing, skin cooling, skin regeneration, moisturizing power, skin elasticity, and skin vitality by the above-mentioned active ingredients. , the efficacy of each component of the second active ingredient can be added to the cosmetic composition.
상기 화장료 조성물은 전술된 성분들 이외에도, 통상적인 화장료 조성물에 배합될 수 있는 추가 성분과 기타 첨가제를 더 포함할 수 있다. In addition to the above-mentioned ingredients, the cosmetic composition may further include additional ingredients and other additives that can be blended into conventional cosmetic compositions.
상기 추가 성분은, 예를 들어, 계면활성제, 보습제, 점증제, pH 조정제, 방부제, 물, 용해보조제, 현탁제, 산화방지제, 금속이온봉쇄제, 살균제, 항염증제, 항미생물제, 가용화제 또는 착향제, 염료, 안료 등을 더 포함할 수 있다. The additional ingredients include, for example, surfactants, humectants, thickeners, pH adjusters, preservatives, water, solubilizers, suspending agents, antioxidants, sequestrants, disinfectants, anti-inflammatory agents, antimicrobial agents, solubilizers or flavoring agents. , dyes, pigments, etc. may be further included.
상기 계면활성제는, 예를 들어, 암모늄라우릴술포석시네이트, 암모늄라우릴설페이트 등과 같은 음이온계 계면활성제와 폴리옥시에틸렌알킬에테르, 폴리옥시에틸렌지방산에스테르, 폴리소르베이트 80등과 같은 비이온성 계면활성제 등이 가능하다. 또한, 3급 지방족 아민염, 알킬트리메칠암모늄클로라이드 등과 같은 양이온성 계면활성제와 베타인, 아미드베타인형과 같은 양쪽성 계면활성제 등이 될 수 있다. The surfactants include, for example, anionic surfactants such as ammonium lauryl sulfosuccinate and ammonium lauryl sulfate, and nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, and polysorbate 80. etc. is possible. In addition, cationic surfactants such as tertiary aliphatic amine salts and alkyltrimethylammonium chloride, and amphoteric surfactants such as betaine and amide betaine types may be used.
상기 보습제는 소듐하이알루로네이트, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 디프로필렌글리콜, 에리스리톨, 소르비톨 등이 될 수 있으며, 점증제는 폴리아크릴레이트, 잔탄검, 메틸셀룰로스, 하이드록시에틸셀룰로스, 카보머, 카라기난, 카르복시메틸셀룰로스, 하이드록시메틸셀룰로스 등의 화합물이 될 수 있다. 또한, pH 조정제는 구체적으로 구연산, 수산화나트륨, 트리에탄올아민, 구연산나트륨, 인산, 인산나트륨, 젖산, 트로메타민 등이 가능하다. The moisturizer may be sodium hyaluronate, glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, erythritol, sorbitol, etc., and the thickener may be polyacrylate, xanthan gum, methylcellulose, hydroxyl It can be compounds such as ethylcellulose, carbomer, carrageenan, carboxymethylcellulose, and hydroxymethylcellulose. Additionally, the pH adjuster may specifically include citric acid, sodium hydroxide, triethanolamine, sodium citrate, phosphoric acid, sodium phosphate, lactic acid, tromethamine, etc.
상기 방부제는 벤조산, 파라옥시안식향산에스테르, 메칠클로로이소치아졸리논의 혼합물, 페녹시에탄올, 디엠디 엠히단토인 등이 될 수 있으며, 산화방지제는 구체적으로 디부틸히드록시톨루엔, 아스코르빈산 등이 가능하다. The preservative may be benzoic acid, paraoxybenzoic acid ester, a mixture of methylchloroisothiazolinone, phenoxyethanol, DMDMhydantoin, etc., and the antioxidant may specifically include dibutylhydroxytoluene, ascorbic acid, etc. do.
상기 금속이온봉쇄제는 에칠렌디아민테트라초산디나트륨, 에칠렌디아민테트라초산테트라나트륨 등이 가능하며, 살균제는 구체적으로 클로르헥시딘 글루코네이트, 4급 암모늄염, 피록톤올아민, 아연피리치온 현탁액, 요도프로피닐 부틸카바메이트, 살리실산 등이 될 수 있다. The metal ion sequestering agent may include disodium ethylenediaminetetraacetate, sodium ethylenediaminetetraacetate, etc., and the disinfectant may specifically include chlorhexidine gluconate, quaternary ammonium salt, pyroctonolamine, zinc pyrithione suspension, and iodopropynyl butyl. It can be carbamate, salicylic acid, etc.
상기 항염증 성분으로는 글리시리진산모노암모늄, 글리시리진산디칼륨, 알란토인 및 이들의 혼합물 등이 가능하며, 항균(항미생물)성분은 구체적으로 페녹시에탄올, 클로르헥시딘, 클로르헥시딘 글루코네이트, 벤조산 및 그의 염, 벤질알코올, 살리실산, 트리클로카르반, 아연피리치온 현탁액 및 그들의 혼합물 등을 사용할 수 있다. The anti-inflammatory ingredients include monoammonium glycyrrhizinate, dipotassium glycyrrhizinate, allantoin, and mixtures thereof, and the antibacterial (antimicrobial) ingredients include phenoxyethanol, chlorhexidine, chlorhexidine gluconate, benzoic acid and its salts, and benzyl. Alcohol, salicylic acid, triclocarban, zinc pyrithione suspension, and mixtures thereof can be used.
상기 가용화제로는 구체적으로 피이지 60-하이드로제네이티드 캐스터오일 등이 될 수 있으며, 상기 착향제는 본 발명의 화장료 조성물 분야에 사용되는 통상의 성분을 사용할 수 있다. The solubilizer may specifically include PEG 60-hydrogenated castor oil, and the flavoring agent may be a common ingredient used in the field of cosmetic compositions of the present invention.
그러나, 상기 추가 성분과 기타 첨가제의 예시물질에 대하여는 전술된 바에 한정되지 않으며, 상기한 유효 성분과 제2 유효 성분의 각 물성과 효능을 저해하지 않는 선에서, 당해 분야에서 통상적으로 사용되는 공지된 성분을 얼마든지 더 포함할 수 있으며, 기타 제형 또는 사용 목적 등에 따라 당업자가 적절하게 적의 선정하여 배합할 수 있다.However, the examples of the additional ingredients and other additives are not limited to the above, and are known to be commonly used in the field as long as they do not impair the properties and efficacy of the active ingredient and the second active ingredient. Any number of additional ingredients may be included, and a person skilled in the art may appropriately select and mix them depending on other formulations or purposes of use.
상기 추가 성분과 기타 첨가제를 구성하는 각 성분의 함량은 서로 독립적으로, 화장료 조성물 총 중량에 대하여, 0.001 내지 5 중량%의 범위 내에서 포함될 수 있다. The content of each ingredient constituting the additional ingredients and other additives may be independently included within the range of 0.001 to 5% by weight based on the total weight of the cosmetic composition.
상기 화장료 조성물은, 잔량의 범위 내에서 정제수를 포함할 수 있다. The cosmetic composition may contain purified water within the remaining amount.
상기 화장료 조성물을 제조하는 방법은, 조성물을 구성하는 모든 성분들을 칭량 및 배합한 후에 가온한 후, 초고압 분산기로 교반 및 혼합하는 공정을 포함할 수 있다. 이때, 각 성분들은 순서대로 투입될 수 있고, 경우에 따라서 순차적으로 투입될 수도 있다. The method of manufacturing the cosmetic composition may include the process of weighing and mixing all the components constituting the composition, heating them, and then stirring and mixing them with an ultra-high pressure disperser. At this time, each component may be added in order, and in some cases, may be added sequentially.
상기 가온은, 50 내지 80℃로, 바람직하게는 60 내지 80℃, 더욱 바람직하게는 75℃로 수행될 수 있다. 이때, 온도가 50℃ 미만이면 조성물간 혼화가 잘 이루어지지 않아서 화장료 성분이 상분리가 되는 문제가 있을 수 있고, 80℃를 초과하면 방부력 및/또는 제형 안정성에 문제가 있을 수 있으므로 상기 온도 범위로 가온한 후, 이 온도에서 초고압 분산기로 교반 및 혼합을 수행하는 것이 바람직하다. The heating may be performed at 50 to 80°C, preferably 60 to 80°C, and more preferably 75°C. At this time, if the temperature is less than 50℃, there may be a problem of phase separation of the cosmetic ingredients due to poor miscibility between compositions, and if the temperature exceeds 80℃, there may be problems with preservative power and/or formulation stability, so it should be kept within the above temperature range. After warming, it is desirable to carry out stirring and mixing with an ultra-high pressure disperser at this temperature.
상기 초고압 분산기로 교반 및 혼합은 압력 800 내지 1,500 bar에서 20분 내지 40분간 수행하며, 바람직하게는 혼합은 압력 800 내지 1,200 bar에서 20분 내지 40분간 수행한다. 이때, 초고압 분산기 내부 온도는 50 내지 80 ℃이고, 초고압 분산기의 출구 온도는 약 10 내지 15℃이다.Stirring and mixing using the ultra-high pressure disperser is performed at a pressure of 800 to 1,500 bar for 20 to 40 minutes, and preferably mixing is performed at a pressure of 800 to 1,200 bar for 20 to 40 minutes. At this time, the internal temperature of the ultra-high pressure disperser is 50 to 80 ℃, and the outlet temperature of the ultra-high pressure disperser is about 10 to 15 ℃.
그러나, 이에 한정되지 않고, 상기 화장료 조성물의 제조방법에 대하여는 당해 분야에서 널리 사용되는 공지된 기술에 따를 수 있다. However, it is not limited to this, and the method for producing the cosmetic composition may follow known techniques widely used in the field.
상기 화장료 조성물은 예를 들어, 수딩젤(soothing gel) Oil-in-Water(수중유형)(O/W), Water-in-Oil(유중수형)(W/O), Water-inSilicone(실리콘중수형)(W/S), Oil-in-Water-in-Oil(유중수중유형)(O/W/O) 또는 Water-in-Oil-in-Water(수중유 중수형)(W/O/W) 제형으로 제조될 수 있으나, 이에 한정되는 것은 아니다. The cosmetic composition is, for example, soothing gel Oil-in-Water (O/W), Water-in-Oil (W/O), Water-inSilicone (silicone-in-water type) )(W/S), Oil-in-Water-in-Oil (O/W/O) or Water-in-Oil-in-Water (W/O/W) ) may be manufactured in a dosage form, but is not limited thereto.
상기 화장료 조성물은 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 젤, 에센스, 크림, 로션, 앰플, 유연 화장수, 영양 화장수, 파우더, 비누, 클렌징, 오일, 파운데이션, 왁스, 팩, 파우더, 팩트, 립 글로즈, 립스틱, 섀도우, 샴푸, 린스 또는 스프레이 형태의 제품으로 제작될 수 있다. The cosmetic composition includes, for example, solution, suspension, emulsion, paste, gel, essence, cream, lotion, ampoule, softening lotion, nourishing lotion, powder, soap, cleansing, oil, foundation, wax, pack, powder, compact. , can be made into lip gloss, lipstick, shadow, shampoo, conditioner or spray form products.
그러나, 상기 화장료 조성물의 적용 예시에 대하여는 이에 한정되는 것은 아니다. 또한, 목적하는 최종 제형 및 제품 형태에 맞게 공지된 기술을 적용하여 제작될 수 있다. However, examples of application of the cosmetic composition are not limited thereto. In addition, it can be manufactured by applying known techniques to suit the desired final dosage form and product form.
상기 화장료 조성물은 단독 또는 중복 도포하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복 도포하여 사용할 수 있다. 또한, 본 발명에 따른 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용 횟수를 달리할 수 있다.The cosmetic composition may be used alone or in multiple applications, or may be used in multiple applications with other cosmetic compositions other than the present invention. Additionally, the cosmetic composition according to the present invention can be used according to conventional usage methods, and the number of uses can be varied depending on the user's skin condition or preference.
이하, 구체적인 실시예와 비교예를 통하여 본 발명의 구성 및 그에 따른 효과를 보다 상세히 설명하고자 한다. 그러나, 본 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것이며, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the configuration of the present invention and its effects will be described in more detail through specific examples and comparative examples. However, these examples are for illustrating the present invention in more detail, and the scope of the present invention is not limited to these examples.
실시예 및 비교예Examples and Comparative Examples
하기 표 1에 따른 성분 조성 및 함량을 적용하여, 로션 제형을 갖는 화장료 조성물을 제조하였다. 구체적인 제조방법은 공지된 기술에 따랐으며, 정제수와 점증제인 잔탄검과 카보머를 사용해 농도를 조절하였고, 로션의 제형을 형성할 수 있도록 하는 공지된 성분에 따르는 기타 첨가제를 포함하였다. 또한, 모든 성분들이 고르게 분산되도록 하기 위해, 75℃로 가온한 후, 초고압 분산기(내부 온도 70℃)로 압력 1,000 bar에서 35분간 교반을 수행하였다. 하기 표 1의 함량 단위는 중량%이다.A cosmetic composition having a lotion formulation was prepared by applying the ingredient composition and content according to Table 1 below. The specific manufacturing method followed a known technique, and the concentration was adjusted using purified water and thickeners xanthan gum and carbomer, and other additives according to known ingredients to form a lotion formulation were included. Additionally, in order to ensure that all components were evenly dispersed, the mixture was heated to 75°C and stirred for 35 minutes at a pressure of 1,000 bar using an ultra-high pressure disperser (internal temperature 70°C). The content unit in Table 1 below is weight%.
<실험예 1: 피부 쿨링 효능 평가><Experimental Example 1: Evaluation of skin cooling efficacy>
실시예 1 내지 실시예 7 및 비교예 1 내지 비교예 3에 따라 제조된 각 로션의 피부 쿨링 효능 평가를 실시하였다. 측정 방법은 다음과 같다. The skin cooling efficacy of each lotion prepared according to Examples 1 to 7 and Comparative Examples 1 to 3 was evaluated. The measurement method is as follows.
만 19~49세 성인 여성 50명을 대상으로, 5명을 1개의 그룹으로 하여 10개 그룹으로 분류한 다음, 로션을 도포하기 전 피험자들의 안면부위의 피부 온도를 측정한 후, 각 로션을 도포한 직후와 30분이 지난 후의 온도를 각각 측정한 다음, 결과를 평균하여 하기 표 2에 나타내었다. Targeting 50 adult women aged 19 to 49, they were divided into 10 groups with 5 people in each group. The skin temperature of the subjects' facial area was measured before applying the lotion, and then each lotion was applied. The temperature was measured immediately after and 30 minutes after the treatment, and the results were averaged and shown in Table 2 below.
상기 표 2에 나타난 바와 같이, 실시예들은 로션 도포 직후와 30분이 경과한 후에도 피부 열감을 낮추는 피부 쿨링 효과가 뛰어난 것을 확인할 수 있었다. 그 중에서도, 실시예 5의 피부 쿨링 효능에 대한 결과가 가장 우수한 것으로 평가되었다. As shown in Table 2, the Examples were confirmed to have an excellent skin cooling effect in reducing skin heat immediately after applying the lotion and even after 30 minutes. Among them, the results for skin cooling efficacy of Example 5 were evaluated as the best.
<실험예 2: 피부 보습력 효능 평가><Experimental Example 2: Evaluation of skin moisturizing efficacy>
실시예 1 내지 실시예 7 및 비교예 1 내지 비교예 3에 따라 제조된 로션의 피부 보습력 개선 효과를 측정하였다. 측정 방법은 다음과 같다. The skin moisturizing effect of the lotions prepared according to Examples 1 to 7 and Comparative Examples 1 to 3 was measured. The measurement method is as follows.
피부 질환이 없는 20~40대 여성 50명을 대상으로 1조당 5명씩 10개조로 나누고, 각 조별로 실시예 1 내지 실시예 7 및 비교예 1 내지 비교예 3의 로션을 매일 2회씩 1개월간 얼굴 전면에 도포하게 하였다. 도포 시작 전 항온, 항습 조건(24도, 습도 40%)에서 corneometer(CM820 courage Khazaka electronic GmbH, Germany)를 이용하여 피부 전도도를 측정하여 기본 값을 삼고, 1주, 2주, 4주 경과 후의 피부 전도도를 측정하여 그 증가율을 평가하였다. 그 결과를 하기 표 3에 나타내었다.50 women in their 20s to 40s without skin disease were divided into 10 groups, 5 people per group, and each group applied the lotion of Examples 1 to 7 and Comparative Examples 1 to 3 on their face twice daily for 1 month. It was applied to the entire surface. Before starting application, skin conductivity was measured using a corneometer (CM820 courage Khazaka electronic GmbH, Germany) under constant temperature and humidity conditions (24 degrees Celsius, 40% humidity), and the skin conductivity was taken as the default value, and the skin conductivity was measured after 1, 2, and 4 weeks. Conductivity was measured and the rate of increase was evaluated. The results are shown in Table 3 below.
상기 표 3에 나타난 바와 같이, 본 발명의 실시예들의 경우 비교예들에 비하 여 피부 전도도 증가율이 매우 우수하였다. 일반적으로 피부 전도도는 피부 수분량에 비례하므로, 상기의 결과로부터 본 발명의 성분 조성을 갖는 화장료는 그렇지 않은 화장료에 비해 피부 수분 함량도 높게 유지한다는 것을 확인할 수 있다. 즉, 본 발명의 일 실시예에 따른 화장료 조성물은 피부 보습력 개선 효과가 탁월한 것을 확인할 수 있었다. As shown in Table 3, the skin conductivity increase rate of the Examples of the present invention was very excellent compared to the Comparative Examples. In general, skin conductivity is proportional to the amount of skin moisture, so it can be seen from the above results that cosmetics containing the ingredient composition of the present invention maintain a higher skin moisture content compared to cosmetics without the composition. That is, it was confirmed that the cosmetic composition according to an embodiment of the present invention had an excellent effect of improving skin moisturizing ability.
<실험예 3: 관능 평가><Experimental Example 3: Sensory Evaluation>
실시예 1 내지 실시예 7 및 비교예 1 내지 비교예 3에 따라 제조된 로션에 대하여, 피부 가려움증 개선, 피부 탄력, 피부 생기(또는 미백)에 대하여 관능 평가를 실시하였다. The lotions prepared according to Examples 1 to 7 and Comparative Examples 1 to 3 were subjected to sensory evaluation for improvement in skin itching, skin elasticity, and skin vitality (or whitening).
특별한 피부 질환이 없는 20~40대 여성 50명을 대상으로 1조당 5명씩 10개조로 나누고, 각 조별로 실시예 1 내지 실시예 7 및 비교예 1 내지 비교예 3의 로션을 매일 2회씩 2개월간 얼굴 전면에 도포하게 하였다. 이후, 시험 대상자에 대하여, 각 로션을 사용하고 난 후, 피부 가려움증 개선, 피부 탄력, 피부 생기(또는 미백)의 각 항목에 대한 주관적인 만족도를 5점 척도법(1점: 매우 불량, 2점: 불량, 3점: 보통, 4점: 양호, 5점: 매우 양호)으로 표시하도록 하였다. 그 결과를 하기 표 4에 나타내었다. 50 women in their 20s to 40s without any special skin diseases were divided into 10 groups, 5 people per group, and each group applied the lotions of Examples 1 to 7 and Comparative Examples 1 to 3 twice daily for 2 months. It was applied to the entire face. After using each lotion, test subjects were asked to rate their subjective satisfaction with each item of skin itchiness improvement, skin elasticity, and skin vitality (or whitening) using a 5-point scale (1 point: very poor, 2 points: poor). , 3 points: average, 4 points: good, 5 points: very good). The results are shown in Table 4 below.
상기 표 4에 나타난 바와 같이, 본 발명의 실시예들의 경우 비교예들에 비하 여 피부 가려움증 개선 효과와, 피부 탄력 및 피부 생기를 높이는 효과가 우수하게 나타나는 것을 확인할 수 있었다. 그 중에서도, 실시예 5에 대한 관능평가 결과가 가장 우수하게 나타났다.As shown in Table 4, it was confirmed that the Examples of the present invention showed superior effects in improving skin itching and increasing skin elasticity and skin vitality compared to the Comparative Examples. Among them, the sensory evaluation results for Example 5 were the most excellent.
본 명세서에서는 본 발명자들이 수행한 다양한 실시예 가운데 몇 개의 예만을 들어 설명하는 것이나 본 발명의 기술적 사상은 이에 한정하거나 제한되지 않고, 당업자에 의해 변형되어 다양하게 실시될 수 있음은 물론이다.In this specification, only a few examples of various embodiments performed by the present inventors are described, but the technical idea of the present invention is not limited or limited thereto, and of course, it can be modified and implemented in various ways by those skilled in the art.
Claims (9)
상기 유효 성분은, 상기 화장료 조성물 총 중량에 대하여, 0.1 내지 8 중량%로 포함되는 것을 특징으로 하는, 화장료 조성물. According to paragraph 1,
A cosmetic composition, characterized in that the active ingredient is contained in an amount of 0.1 to 8% by weight based on the total weight of the cosmetic composition.
상기 구아이아줄렌(Guaiazulene), 히알루론산(Hyaluronic acid), 시아노코발라민(Cyanocobalamin) 및 동백 오일(camellia oil)의 배합비는, 1 : 1~1.3 : 0.8~1 : 0.5~0.7의 중량비인 것을 특징으로 하는, 화장료 조성물.According to paragraph 1,
The mixing ratio of Guaiazulene, Hyaluronic acid, Cyanocobalamin, and camellia oil is a weight ratio of 1: 1 to 1.3: 0.8 to 1: 0.5 to 0.7. Characterized by a cosmetic composition.
상기 화장료 조성물은 총 중량에 대하여, 천연 재료 추출물을 포함하는 제2 유효 성분을 0.01 내지 3.5 중량%로 더 포함하는 것을 특징으로 하는, 화장료 조성물.According to paragraph 1,
The cosmetic composition further comprises 0.01 to 3.5% by weight of a second active ingredient containing extracts of natural ingredients, based on the total weight.
상기 제2 유효 성분은, 애기수영 추출물, 모란뿌리 추출물, 광나무 추출물, 나이아신 아마이드, 판토테닉 애씨드, 알란토인, 오렌지 추출물, 비오틴, 판테놀, 병풀 추출물, 알로에 추출물 및 이들의 조합 중에서 선택되는 어느 하나인 것을 특징으로 하는, 화장료 조성물.According to paragraph 4,
The second active ingredient is any one selected from the group consisting of Aerobiculus vulgaris extract, peony root extract, L. chinensis extract, niacinamide, pantothenic acid, allantoin, orange extract, biotin, panthenol, Centella asiatica extract, aloe extract, and combinations thereof. Characterized by a cosmetic composition.
상기 화장료 조성물은, 소듐하이알루로네이트, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 디프로필렌글리콜, 에리스리톨 및 소르비톨 중에서 선택되는 1종 이상의 보습제를 더 포함하는 것을 특징으로 하는, 화장료 조성물.According to paragraph 1,
The cosmetic composition further comprises at least one moisturizing agent selected from sodium hyaluronate, glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, erythritol, and sorbitol.
상기 화장료 조성물은, 폴리아크릴레이트, 잔탄검, 메틸셀룰로스, 하이드록시에틸셀룰로스, 카보머, 카라기난, 카르복시메틸셀룰로스 및 하이드록시메틸셀룰로스 중에서 선택되는 1종 이상의 점증제를 더 포함하는 것을 특징으로 하는, 화장료 조성물.According to paragraph 1,
The cosmetic composition further comprises one or more thickeners selected from polyacrylate, xanthan gum, methylcellulose, hydroxyethylcellulose, carbomer, carrageenan, carboxymethylcellulose and hydroxymethylcellulose, Cosmetic composition.
상기 화장료 조성물은, 구연산, 수산화나트륨, 트리에탄올아민, 구연산나트륨, 인산, 인산나트륨, 젖산, 트로메타민 중에서 선택되는 1종 이상의 pH 조정제를 더 포함하는 것을 특징으로 하는, 화장료 조성물.According to paragraph 1,
The cosmetic composition further comprises one or more pH adjusters selected from citric acid, sodium hydroxide, triethanolamine, sodium citrate, phosphoric acid, sodium phosphate, lactic acid, and tromethamine.
상기 화장료 조성물은, 용액, 현탁액, 유탁액, 페이스트, 젤, 에센스, 크림, 로션, 앰플, 유연 화장수, 영양 화장수, 파우더, 비누, 클렌징, 오일, 파운데이션, 왁스, 팩, 파우더, 팩트, 립 글로즈, 립스틱, 섀도우, 샴푸, 린스 또는 스프레이 형태로 제조되는 것을 특징으로 하는, 화장료 조성물.According to paragraph 1,
The cosmetic composition includes solution, suspension, emulsion, paste, gel, essence, cream, lotion, ampoule, softening lotion, nourishing lotion, powder, soap, cleansing, oil, foundation, wax, pack, powder, pact, lip gloss. A cosmetic composition, characterized in that it is manufactured in the form of lipstick, shadow, shampoo, rinse or spray.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230192378A KR102631008B1 (en) | 2023-12-27 | 2023-12-27 | Cosmetic composition and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230192378A KR102631008B1 (en) | 2023-12-27 | 2023-12-27 | Cosmetic composition and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102631008B1 true KR102631008B1 (en) | 2024-01-30 |
Family
ID=89714904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230192378A KR102631008B1 (en) | 2023-12-27 | 2023-12-27 | Cosmetic composition and method for producing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102631008B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150145745A (en) | 2014-06-19 | 2015-12-31 | 주식회사 코스메카코리아 | A method of preparing cosmetic composition for moisturizing the skin and promoting the differenciation of keratinocyte cell comprising the agar and the cosmetic composition prepared therefrom |
KR101868263B1 (en) * | 2017-01-10 | 2018-06-18 | 윤경애 | moisturizing cosmetic composition |
KR102040490B1 (en) * | 2017-12-15 | 2019-11-05 | 주식회사 씨앤피코스메틱스 | A cosmetic composition having excellent skin cooling with skin moisturizing effect |
KR20210012144A (en) * | 2019-07-24 | 2021-02-03 | 민현경 | Diy kit for manufacturing natural cosmetic |
KR102244695B1 (en) * | 2020-02-26 | 2021-04-27 | 김경표 | Functional mixed cosmetic composition and user-customized fuuntional cosmetic kit using the same |
EP4275675A1 (en) * | 2021-01-08 | 2023-11-15 | Dae Won Pharmaceutical Co., Ltd. | Drug delivery contact lens and ophthalmic pharmaceutical composition |
-
2023
- 2023-12-27 KR KR1020230192378A patent/KR102631008B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150145745A (en) | 2014-06-19 | 2015-12-31 | 주식회사 코스메카코리아 | A method of preparing cosmetic composition for moisturizing the skin and promoting the differenciation of keratinocyte cell comprising the agar and the cosmetic composition prepared therefrom |
KR101868263B1 (en) * | 2017-01-10 | 2018-06-18 | 윤경애 | moisturizing cosmetic composition |
KR102040490B1 (en) * | 2017-12-15 | 2019-11-05 | 주식회사 씨앤피코스메틱스 | A cosmetic composition having excellent skin cooling with skin moisturizing effect |
KR20210012144A (en) * | 2019-07-24 | 2021-02-03 | 민현경 | Diy kit for manufacturing natural cosmetic |
KR102244695B1 (en) * | 2020-02-26 | 2021-04-27 | 김경표 | Functional mixed cosmetic composition and user-customized fuuntional cosmetic kit using the same |
EP4275675A1 (en) * | 2021-01-08 | 2023-11-15 | Dae Won Pharmaceutical Co., Ltd. | Drug delivery contact lens and ophthalmic pharmaceutical composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI433680B (en) | New cosmetic and/or pharmaceutical compositions and their applications | |
KR102307509B1 (en) | Composition for hairloss and scalp care | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
JP2009155227A (en) | Living body tissue repair promoting drug | |
KR102015173B1 (en) | Low irritating cosmetic composition for skin whitening | |
KR20160131387A (en) | Composition for skin care | |
KR102369387B1 (en) | Cosmetic Composition for prevention of depilation or improvement of hair growth | |
JP2010241762A (en) | Cosmetic | |
KR20160114794A (en) | A cosmetic composition for skin improvement comprising bulb extract | |
JP6731699B2 (en) | Method of manufacturing chemical composition | |
KR100981343B1 (en) | The cosmetic composition for the reduction of skin pores | |
KR102058294B1 (en) | Cosmetic composition for skin regenerating containing complex extracts of snail mucus, Boswellia serrata resin and Aloe barbadensis leaf, and cream comprising the same | |
KR102027647B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin | |
KR102631008B1 (en) | Cosmetic composition and method for producing the same | |
FR3033699A1 (en) | EXTRACT OF CHINA PEPPER, COMPOSITION COMPRISING SAID EXTRACT AND COSMETIC USE | |
KR100946583B1 (en) | Cosmetic Composition for Skin Moisturizing Comprising the Extract of Orostachys japonicus as Active Ingredient | |
JPH07277920A (en) | Cosmetic containing steam-distilled water and/or extract of lemongrass | |
JP2006022050A (en) | Cosmetic | |
EA012881B1 (en) | Cosmetic composition with increasedho content | |
KR101436819B1 (en) | Cosmetic composition for moisturing, soothing skin and improving acne | |
KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
KR20090056302A (en) | Composition for skin external application comprising astragalus membranaceus extract prepared by using pottery extractor | |
JPH08157337A (en) | Hair cosmetic | |
KR102513929B1 (en) | Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care | |
KR102667625B1 (en) | Cosmetic composition for improving skin barrier and skin moisturing and method for maufacturing thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A302 | Request for accelerated examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |